ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Moderna opens mRNA manufacturing facility

by Ryan Cross
July 20, 2018 | APPEARED IN VOLUME 96, ISSUE 30

 

09630-buscon15-modernacxd.jpg
Credit: Moderna Therapeutics
Moderna just opened this mRNA manufacturing facility in Norwood, Mass.

Moderna Therapeutics, the Cambridge, Mass.-based messenger RNA (mRNA) therapeutics start-up, has opened a $110 million, 18,600-m2 production facility. The plant will house over 200 employees and make mRNA molecules for the company’s clinical programs, including its ischemic heart disease partnership with AstraZeneca. The plant will also make mRNA for Moderna’s vaccine programs, including vaccines for infectious diseases, mosquito-borne diseases, and cancer.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment